Miniature, Wearable PET Scanner Ready for Use on Lab Rats
By MedImaging International staff writers Posted on 24 Mar 2011 |
Scientists have demonstrated the effectiveness of a "wearable,” portable positron emission tomography (PET) scanner they have developed for research in laboratory rats. The technology will provide neuroscientists a new tool for simultaneously assessing brain function and behavior in fully awake, moving animals.
The researchers from the US Department of Energy's (DOE) Brookhaven National Laboratory, Stony Brook University (Stony Brook, NY, USA) described the tool and validation studies in the April 2011 issue of the journal Nature Methods. "PET is a powerful tool for studying the molecular processes that occur in the brain,” said Dr. Paul Vaska, head of PET physics at Brookhaven with a joint appointment at Stony Brook, who led the development of the portable scanner together with Brookhaven colleagues Dr. David Schlyer and DR. Craig Woody. PET studies in animals at Brookhaven and elsewhere have helped to reveal the molecular foundations of conditions such as drug addiction.
However, examining animals with PET imaging has required general anesthesia or other techniques to immobilize the animals. "Immobilization and anesthesia make it impossible to simultaneously study neurochemistry and the animals' behavior--the actions resulting from what goes on in the brain,” Dr. Schlyer said. "Our approach was to eliminate the need for restraint by developing a PET scanner that would move with the animal, thus opening up the possibility of directly correlating the imaging data with behavioral data acquired at the same time.”
After several years of development, the scientists have arrived at a design for a miniature, portable, donut-shaped PET scanner that can be "worn” like a collar on a rat's head for simultaneous studies of brain function and behavior. Weighing only 250 g, the device--named RatCAP (rat conscious animal PET), is counterbalanced by a system of springs and motion stabilizers to allow the animal significant freedom of movement.
Measurements of the rats' stress hormones indicated only moderate and temporary increases. "Rats wearing the device appear to adapt well and move freely about their environment,” Dr. Woody said.
To validate the use of the wearable scanner for simultaneous studies of brain function and behavior, the scientists conducted tests with 11C-raclopride, a typically used PET radiotracer, which incorporates a radioactive, positron-emitting isotope of the element carbon. When the positrons interact with electrons in ordinary matter, they immediately annihilate one another, emitting back-to-back gamma rays. Detectors in the circular PET scanner detect the signals from these back-to-back gamma rays to identify the location and concentration of the tracer in the body.
The tracer 11C-raclopride binds to receptors for dopamine, a brain chemical involved in movement, reward, and memory formation. A higher signal from the tracer means that less natural dopamine is in that specific part of the brain; a low signal indicates that that particular part of the brain has released dopamine (which binds to its receptors, thereby blocking the tracer from binding).
The key test was to see if the wearable scanner could be used to correlate dopamine levels with behavior--in this case, the rats' activity, i.e., movement, within their chambers. Unexpectedly, the level of activity was inversely related to dopamine levels--meaning, the more active the animals were, the lower the level of dopamine (as indicated by a stronger tracer signal).
"This is perhaps a counterintuitive result because behavioral activation is typically associated with an increase in dopamine release,” said Dr. Daniela Schulz, a Brookhaven behavioral neuroscientist and lead author of the paper. "So our method provides data which may challenge traditional paradigms and ultimately improve our understanding of the dopamine system. But regardless of the direction, the results clearly demonstrate that RatCAP can correlate brain function measurements with behavioral measures in a useful way.”
The scientists also presented study findings comparing RatCAP-wearing rats moving freely about their cages with animals that had been anesthetized, as well as comparisons of two methods of administering the tracer--injecting it all at once and in a steady infusion to maintain a constant concentration in the blood. "These measurements will help us further refine the technique and aid in our assessment of results obtained with RatCAP in comparison with other study techniques,” Dr. Schulz stated.
The researchers' next step will be to use RatCAP to explore distinct behavioral expressions that can be correlated with simultaneously acquired PET data. This research should enhance understanding of a wide array of human medical conditions including cancer, drug addiction, Alzheimer's and Parkinson's diseases, and normal aging. Earlier similar research led to the development of several promising treatment strategies.
Related Links:
Brookhaven National Laboratory, Stony Brook University
The researchers from the US Department of Energy's (DOE) Brookhaven National Laboratory, Stony Brook University (Stony Brook, NY, USA) described the tool and validation studies in the April 2011 issue of the journal Nature Methods. "PET is a powerful tool for studying the molecular processes that occur in the brain,” said Dr. Paul Vaska, head of PET physics at Brookhaven with a joint appointment at Stony Brook, who led the development of the portable scanner together with Brookhaven colleagues Dr. David Schlyer and DR. Craig Woody. PET studies in animals at Brookhaven and elsewhere have helped to reveal the molecular foundations of conditions such as drug addiction.
However, examining animals with PET imaging has required general anesthesia or other techniques to immobilize the animals. "Immobilization and anesthesia make it impossible to simultaneously study neurochemistry and the animals' behavior--the actions resulting from what goes on in the brain,” Dr. Schlyer said. "Our approach was to eliminate the need for restraint by developing a PET scanner that would move with the animal, thus opening up the possibility of directly correlating the imaging data with behavioral data acquired at the same time.”
After several years of development, the scientists have arrived at a design for a miniature, portable, donut-shaped PET scanner that can be "worn” like a collar on a rat's head for simultaneous studies of brain function and behavior. Weighing only 250 g, the device--named RatCAP (rat conscious animal PET), is counterbalanced by a system of springs and motion stabilizers to allow the animal significant freedom of movement.
Measurements of the rats' stress hormones indicated only moderate and temporary increases. "Rats wearing the device appear to adapt well and move freely about their environment,” Dr. Woody said.
To validate the use of the wearable scanner for simultaneous studies of brain function and behavior, the scientists conducted tests with 11C-raclopride, a typically used PET radiotracer, which incorporates a radioactive, positron-emitting isotope of the element carbon. When the positrons interact with electrons in ordinary matter, they immediately annihilate one another, emitting back-to-back gamma rays. Detectors in the circular PET scanner detect the signals from these back-to-back gamma rays to identify the location and concentration of the tracer in the body.
The tracer 11C-raclopride binds to receptors for dopamine, a brain chemical involved in movement, reward, and memory formation. A higher signal from the tracer means that less natural dopamine is in that specific part of the brain; a low signal indicates that that particular part of the brain has released dopamine (which binds to its receptors, thereby blocking the tracer from binding).
The key test was to see if the wearable scanner could be used to correlate dopamine levels with behavior--in this case, the rats' activity, i.e., movement, within their chambers. Unexpectedly, the level of activity was inversely related to dopamine levels--meaning, the more active the animals were, the lower the level of dopamine (as indicated by a stronger tracer signal).
"This is perhaps a counterintuitive result because behavioral activation is typically associated with an increase in dopamine release,” said Dr. Daniela Schulz, a Brookhaven behavioral neuroscientist and lead author of the paper. "So our method provides data which may challenge traditional paradigms and ultimately improve our understanding of the dopamine system. But regardless of the direction, the results clearly demonstrate that RatCAP can correlate brain function measurements with behavioral measures in a useful way.”
The scientists also presented study findings comparing RatCAP-wearing rats moving freely about their cages with animals that had been anesthetized, as well as comparisons of two methods of administering the tracer--injecting it all at once and in a steady infusion to maintain a constant concentration in the blood. "These measurements will help us further refine the technique and aid in our assessment of results obtained with RatCAP in comparison with other study techniques,” Dr. Schulz stated.
The researchers' next step will be to use RatCAP to explore distinct behavioral expressions that can be correlated with simultaneously acquired PET data. This research should enhance understanding of a wide array of human medical conditions including cancer, drug addiction, Alzheimer's and Parkinson's diseases, and normal aging. Earlier similar research led to the development of several promising treatment strategies.
Related Links:
Brookhaven National Laboratory, Stony Brook University
Latest Nuclear Medicine News
- Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
- Novel PET Technique Visualizes Spinal Cord Injuries to Predict Recovery
- Next-Gen Tau Radiotracers Outperform FDA-Approved Imaging Agents in Detecting Alzheimer’s
- Breakthrough Method Detects Inflammation in Body Using PET Imaging
- Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients
- Combining Advanced Imaging Technologies Offers Breakthrough in Glioblastoma Treatment
- New Molecular Imaging Agent Accurately Identifies Crucial Cancer Biomarker
- New Scans Light Up Aggressive Tumors for Better Treatment
- AI Stroke Brain Scan Readings Twice as Accurate as Current Method
- AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer
- New Imaging Agent to Drive Step-Change for Brain Cancer Imaging
- Portable PET Scanner to Detect Earliest Stages of Alzheimer’s Disease
Channels
Radiography
view channel
AI Improves Early Detection of Interval Breast Cancers
Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read moreMRI
view channel
Cutting-Edge MRI Technology to Revolutionize Diagnosis of Common Heart Problem
Aortic stenosis is a common and potentially life-threatening heart condition. It occurs when the aortic valve, which regulates blood flow from the heart to the rest of the body, becomes stiff and narrow.... Read more
New MRI Technique Reveals True Heart Age to Prevent Attacks and Strokes
Heart disease remains one of the leading causes of death worldwide. Individuals with conditions such as diabetes or obesity often experience accelerated aging of their hearts, sometimes by decades.... Read more
AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans
Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read moreUltrasound
view channel.jpeg)
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read more
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read moreGeneral/Advanced Imaging
view channel
AI-Based CT Scan Analysis Predicts Early-Stage Kidney Damage Due to Cancer Treatments
Radioligand therapy, a form of targeted nuclear medicine, has recently gained attention for its potential in treating specific types of tumors. However, one of the potential side effects of this therapy... Read more
CT-Based Deep Learning-Driven Tool to Enhance Liver Cancer Diagnosis
Medical imaging, such as computed tomography (CT) scans, plays a crucial role in oncology, offering essential data for cancer detection, treatment planning, and monitoring of response to therapies.... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more